CD19 and B-cell non-Hodgkin lymphoma: Similar observations were made for B cell lymphoma, where CD19 isoforms with exon 2 and exons 5–6 aberrations (that could affect FMC63 epitope) were detected in patients’ samples and were found to be more common after relapse.